Pregnancy, perinatal and childhood outcomes in women with and without polycystic ovary syndrome and metformin during pregnancy: a nationwide population-based study.
Romina FornesJohanna SiminMinh Hanh NguyenGonzalo CruzNicolás CrisostoMaartje van der SchaafLars EngstrandNele BrusselaersPublished in: Reproductive biology and endocrinology : RB&E (2022)
PCOS was associated with increased risks of adverse pregnancy and perinatal outcomes and childhood obesity. Metformin appears to reduce these risks in mothers with polycystic ovary syndrome and their children; but may increase the risk of childhood-obesity in children form women without PCOS.